Cabaletta Bio(CABA)

持股变动声明

Cabaletta Bio(CABA)03-05 06:55

$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025027  Size: 5 KB 网页链接查看全文

股东委托书协议

Cabaletta Bio(CABA)04-23 19:05

$Cabaletta Bio(CABA)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-105870  Act: 34  Size: 624 KB 网页链接查看全文

其他

Cabaletta Bio(CABA)04-23 19:15

$Cabaletta Bio(CABA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-105890  Act: 34  Size: 162 KB 网页链接查看全文

季度财报

Cabaletta Bio(CABA)05-15 19:55

$Cabaletta Bio(CABA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060045  Act: 34  Size: 7 MB 网页链接查看全文

当期报告

Cabaletta Bio(CABA)05-15 19:15

$Cabaletta Bio(CABA)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-24-138874  Act: 34  Size: 10 MB 网页链接查看全文

持股变动声明

Cabaletta Bio(CABA)03-05 06:45

$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025002  Size: 5 KB 网页链接查看全文

持股变动声明

Cabaletta Bio(CABA)03-05 06:55

$Cabaletta Bio(CABA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025039  Size: 5 KB 网页链接查看全文

员工持股计划

Cabaletta Bio(CABA)03-21 19:55

$Cabaletta Bio(CABA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-24-073318  Act: 33  Size: 55 KB 网页链接查看全文

年度财报

Cabaletta Bio(CABA)03-21 19:35

$Cabaletta Bio(CABA)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-034422  Act: 34  Size: 10 MB 网页链接查看全文

当期报告

Cabaletta Bio(CABA)03-21 19:15

$Cabaletta Bio(CABA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-073294  Act: 34  Size: 224 KB 网页链接查看全文

二麻麻04-08 22:02

$Cabaletta Bio(CABA)$
From Fred Alger Management: Cabaletta是一家临床阶段的生物技术公司，专注于发现和开发自身免疫性疾病的靶向细胞疗法。
该公司的主要候选药物 CABA-201 是一种治疗狼疮和肌炎的细胞疗法，美国食品和药物管理局已接受 CABA-201 的新药申请，为 1/2 期的初步读数...查看全文

guanwang5242023-09-06 09:24

$Cabaletta Bio(CABA)$ 这是一个庄家自娱自乐的股票查看全文

只抄右侧底2023-07-01 01:26

$Cabaletta Bio(CABA)$ 有去年10月$0.7 拿到今年2月$12 的兄弟姐妹么？出来说下心得。查看全文

guanwang5242023-01-31 23:17

$Cabaletta Bio(CABA)$ 美国最强的庄股，厉害啊，就是不敢做空它查看全文

guanwang5242023-01-27 23:58

$Cabaletta Bio(CABA)$ 一个庄家自娱自乐的股票查看全文

guanwang5242023-01-05 23:12

$Cabaletta Bio(CABA)$ 这个庄股厉害啊查看全文

guanwang5242022-12-29 23:25

$Cabaletta Bio(CABA)$ 美股庄股牛逼啊查看全文

guanwang5242022-12-23 22:25

$Cabaletta Bio(CABA)$ 会不会来个一天跌掉80%？查看全文

guanwang5242022-12-21 22:48

$Cabaletta Bio(CABA)$ 美国庄股厉害查看全文

产业链观察2022-10-11 19:19

药闻▶2022年10月11日，中国南京和上海，美国宾夕法尼亚州费城和加利福尼亚州圣何塞，——驯鹿生物（“IASO Bio”），一家处于临床阶段、致力于细胞创新药物开发的生物制药公司与$Cabaletta Bio(CABA)$ ，一家致力于针对自身免疫性疾病患者开发和商业化的首个靶向细胞疗法的临床阶段...查看全文

$Cabaletta Bio(CABA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-10-30 AccNo: 0001193125-19-277804 Size: 70 KB 网页链接

$Cabaletta Bio(CABA)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2019-10-25 AccNo: 0001193125-19-274807 Size: 4 MB 网页链接

$Cabaletta Bio(CABA)$ CERT - Filed: 2019-10-24 AccNo: 0001354457-19-000546 Size: 86 KB 网页链接

$Cabaletta Bio(CABA)$ S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] Filed: 2019-10-24 AccNo: 0001193125-19-273939 Size: 56 KB 网页链接

$Cabaletta Bio(CABA)$ EFFECT - Notice of Effectiveness Filed: 2019-10-24 AccNo: 9999999995-19-002384 Size: 1 KB 网页链接

$Cabaletta Bio(CABA)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2019-10-23 AccNo: 0001193125-19-272558 Size: 13 KB 网页链接

$Cabaletta Bio(CABA)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-10-16 AccNo: 0001193125-19-268040 Size: 5 MB 网页链接